Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
289 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 269 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRALUENT | 150MG | SOLUTION | Resolved | 2019-01-25 | 2019-02-27 | 73630 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2019-04-02 | 2019-05-10 | 80308 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2021-04-09 | 2021-05-04 | 137220 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2022-11-29 | 2022-12-23 | 176325 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-01-17 | 2023-01-30 | 181300 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-05-17 | 2023-06-01 | 192669 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2024-05-27 | 2024-06-06 | 228879 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2018-09-26 | 2019-08-12 | 62424 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2022-03-16 | 2022-07-12 | 156783 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2023-07-19 | 2023-07-21 | 199221 |
| RENAGEL | 800MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-12 | 255211 |
| RENVELA | 800MG | TABLET | Resolved | 2019-01-04 | 2019-01-10 | 71284 |
| RENVELA | 800MG | TABLET | Resolved | 2024-02-16 | 2024-05-15 | 219863 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Resolved | 2024-07-26 | 2025-04-03 | 233720 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Resolved | 2024-10-22 | 2025-04-03 | 240885 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2019-05-28 | 2019-10-15 | 84937 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2021-02-16 | 2021-05-22 | 134202 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2023-10-30 | 2024-02-23 | 208624 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2018-01-10 | 2018-02-02 | 35644 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79293 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| FLAGYL | 10% | CREAM | Discontinued | 2024-03-28 | 2024-11-20 | 223877 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| MOZOBIL | 20MG | SOLUTION | To be discontinued | 2025-03-31 | 2025-03-31 | 253686 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
| NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |